Appoints Experienced Consumer Packaged Goods
Executive Catherine "Triona" Schmelter as EVP and President,
Consumer Self-Care Americas (CSCA) and Global Portfolio
Optimization
DUBLIN, Sept. 11,
2023 /PRNewswire/ -- Perrigo Company plc (NYSE:
PRGO), a leading provider of Consumer Self-Care Products, today
announced the appointment of Catherine "Triona" Schmelter as
Executive Vice President and President, Consumer Self-Care Americas
(CSCA) and Global Portfolio Optimization. In this role, Ms.
Schmelter will lead the strategic direction, growth, and
profitability of the CSCA business in addition to overseeing the
global portfolio evolution process to consistently deliver
Perrigo's long-term growth algorithm. Ms. Schmelter will report to
President and CEO Patrick
Lockwood-Taylor.
Mr. Lockwood-Taylor commented, "We are delighted to welcome
Triona to the Perrigo team as EVP & President of CSCA and head
of Global Portfolio Optimization, a newly created position. Triona
joins at an exciting time to lead the CSCA business and evolve
Perrigo's global self-care portfolio to achieve our sustainable and
value accretive growth objectives. She brings an important set of
skills to this position through her experience in leading both
branded and private label businesses. I am confident that her fresh
perspectives and deep consumer insights will further leverage
CSCA's scale assets and position our global self-care portfolio to
win with consumers."
Prior to joining Perrigo, Ms. Schmelter was most recently
at Treehouse Foods, where she served as Chief Transformation
Officer, responsible for growth acceleration and capability
building initiatives. Prior to this role, Ms. Schmelter led the
Meal Solutions business, where she drove improvements in pricing
realization and customer service leading to category margin
expansion. Previously, Ms. Schmelter led the successful turnaround
of both the Meals and Condiments divisions at Treehouse Foods by
reshaping the portfolio around premium categories, reorganizing
teams around strategic priorities and improving relationships with
top customers. Prior to Treehouse Foods, Ms. Schmelter spent 10
years at Kraft Foods in various leadership roles, including Vice
President of Meals, after beginning her CPG career at General
Mills. She holds a Bachelor of Arts degree in accounting and art
history from the University of Notre
Dame and a Master of Business Administration in marketing
and finance from the Northwestern
University Kellogg Graduate School. Ms. Schmelter also
serves as a Non-Executive Director with Steelcase Inc., a publicly
traded company headquartered in Grand
Rapids, Michigan.
James E. Dillard III will be
departing the Company to pursue other opportunities. Mr.
Lockwood-Taylor noted, "We thank Jim for his many contributions to
Perrigo in his initial role as EVP and Chief Scientific Officer in
2019 and as EVP and President, CSCA, since October 2021. We
wish him continued success."
About Perrigo
Perrigo Company plc (NYSE: PRGO) is a leading provider of
Consumer Self-Care Products and over-the-counter (OTC) health and
wellness solutions that enhance individual well-being by empowering
consumers to proactively prevent or treat conditions that can be
self-managed. Visit Perrigo online at www.perrigo.com.
Forward-Looking Statements
Certain statements in this press release are "forward-looking
statements." These statements relate to future events or the
Company's future financial performance and involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, levels of activity, performance or achievements of
the Company or its industry to be materially different from those
expressed or implied by any forward-looking statements. In some
cases, forward-looking statements can be identified by terminology
such as "may," "will," "could," "would," "should," "expect,"
"forecast," "plan," "anticipate," "intend," "believe," "estimate,"
"predict," "potential" or the negative of those terms or other
comparable terminology. The Company has based these forward-looking
statements on its current expectations, assumptions, estimates and
projections. While the Company believes these expectations,
assumptions, estimates and projections are reasonable, such
forward-looking statements are only predictions and involve known
and unknown risks and uncertainties, many of which are beyond the
Company's control, including: supply chain impacts on the Company's
business, including those caused or exacerbated by armed conflict,
trade and other economic sanctions and/or disease; general
economic, credit, and market conditions; the impact of the war in
Ukraine and any escalation
thereof, including the effects of economic and political sanctions
imposed by the United States,
United Kingdom, European Union,
and other countries related thereto; the outbreak or escalation of
conflict in other regions where we do business; future impairment
charges, if we determine that the carrying amount of specific
assets may not be recoverable from the expected future cash flows
of such assets; customer acceptance of new products; competition
from other industry participants, some of whom have greater
marketing resources or larger market shares in certain product
categories than the Company does; pricing pressures from customers
and consumers; resolution of uncertain tax positions and any
litigation relating thereto, ongoing or future government
investigations and regulatory initiatives; uncertainty regarding
the Company's ability to obtain and maintain its regulatory
approvals; potential costs and reputational impact of product
recalls or sales halts; potential adverse changes to U.S. and
foreign tax, healthcare and other government policy; the effect of
the coronavirus (COVID-19) pandemic and its variants; the timing,
amount and cost of any share repurchases (or the absence thereof);
fluctuations in currency exchange rates and interest rates; the
Company's ability to achieve the benefits expected from the sale of
its Rx business and the risk that potential costs or liabilities
incurred or retained in connection with that transaction may exceed
the Company's estimates or adversely affect the Company's business
or operations; the Company's ability to achieve the benefits
expected from the acquisitions of Héra SAS ("HRA Pharma") and
Nestlé's Gateway infant formula plant along with the U.S. and
Canadian rights to the GoodStart® infant formula brand and other
related formula brands ("Gateway") and/or the risks that the
Company's synergy estimates are inaccurate or that the Company
faces higher than anticipated integration or other costs in
connection with the acquisitions; risks associated with the
integration of HRA Pharma and Gateway, including the risk that
growth rates are adversely affected by any delay in the integration
of sales and distribution networks; the consummation and success of
other announced and unannounced acquisitions or dispositions, and
the Company's ability to realize the desired benefits thereof; and
the Company's ability to execute and achieve the desired benefits
of announced cost-reduction efforts and other strategic initiatives
and investments, including the Company's ability to achieve the
expected benefits from its Supply Chain Reinvention Program.
Adverse results with respect to pending litigation could have a
material adverse impact on the Company's operating results, cash
flows and liquidity, and could ultimately require the use of
corporate assets to pay damages, reducing assets that would
otherwise be available for other corporate purposes. These and
other important factors, including those discussed under "Risk
Factors" in the Company's Form 10-K for the year ended December 31, 2022, as well as the Company's
subsequent filings with the United States Securities and Exchange
Commission, may cause actual results, performance, or achievements
to differ materially from those expressed or implied by these
forward-looking statements. The forward-looking statements in this
press release are made only as of the date hereof, and unless
otherwise required by applicable securities laws, the Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/perrigo-announces-leadership-update-301923747.html
SOURCE Perrigo Company plc